Newsletter : An Abundance of Rare

There are over 7000 rare diseases affecting millions worldwide. 
Though they appear rare, still rare diseases are very much prevalent. Rare diseases pose a huge burden on the global healthcare system, affecting the quality of lives of millions of patients collectively.
There are many companies working on finding cure for rare diseases.
The Top 10 Companies in Rare Disease Segment are:
Novartis, Roche, Celgene, Shire (Takeda), BMS, Merck, J&J, Pfizer, Sanofi and Alexion. Additionally, there are many new companies working to get a rare disease therapy to market.
Newsletter : An Abundance of Rare
https://www.delveinsight.com/whitepaper-newsletter/an-abundance-of-rare

Comments

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

The Need And The Importance Of The Healthcare Reports for the Pharma Companies